T-Cypher Bio
Maria Busz is a Principal Scientist at T-Cypher Bio with a background in oncology disease biology. Prior to their current role, Maria was a Senior Scientist at Immunocore, specializing in single cell group research. Maria's experience also includes working as a Scientist at Newcastle University where Maria conducted research on protein synthesis in human mitochondria. Maria also worked as a Biotechnologist at BioTe21, focusing on genetic constructs and diagnostics tests. Maria has interned at various institutions, including University Children Hospital of Cracow, where Maria assisted in genetic diagnosis tests and microbiology diagnostic tests. Maria holds a Master of Science in Biotechnology and has completed post-diploma studies in Molecular Biology.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.